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Accuracy of Ultrasonography-Guided Fine-Needle Aspiration
in Detecting Persistent Nodal Disease
After Chemoradiotherapy
Gitanjali M. Fleischman, MD; Brian D. Thorp, MD; Megan Difurio, MD; Trevor G. Hackman, MD
IMPORTANCE Few patients with persistent adenopathy following chemoradiotherapy (CRT)
for head and neck squamous cell carcinoma harbor viable disease. Improved selectivity for
surgical salvage is needed to prevent unnecessary salvage neck dissection.
OBJECTIVE To determine whether ultrasonography-guided fine-needle aspiration (FNA) can
be used to identify viable cancer cells in the lymph nodes of patients with persistent
radiographic adenopathy following CRT.
DESIGN, SETTING, AND PARTICIPANTS A pilot study included patients undergoing preoperative
ultrasonography-guided FNA of lymph nodes considered suspicious on radiography prior to
planned neck dissection at a quaternary care facility from February 28, 2011, to March 18,
2013. Data analysis was performed from April 28 to December 24, 2013. Patients treated for
head and neck squamous cell carcinomawith CRT whowere determined to have persistent
neck disease on a 6-week posttreatment computed tomographic scan of the neck and
scheduled for salvage neck dissection were considered candidates for this pilot study. All
patients enrolled in the study underwent ultrasonography-guided FNA of the suspicious
lymph nodes within 2 weeks of the planned neck dissection. The cytopathologist reading the
samples was blinded to the patient’s identity.
EXPOSURES Fine-needle aspiration with a 23- to 25-gauge needle following CRT.
MAIN OUTCOMES ANDMEASURES The accuracy of ultrasonography-guided FNA cytologic
results was compared with the standard of surgical pathologic examination of neck dissection
specimens.
RESULTS Fourteen patients (11 [79%]men; mean [SD] age, 57.8 [11.2] years) were enrolled
in this pilot study; data were collected on 17 lymph nodes. Among these 14 patients with
incomplete radiographic clinical response, 17 lymph node aspirations were performed.
Ultrasonography-guided FNA identified squamous cell carcinoma in the aspirates of 4 (80%)
of the 5 nodes with squamous cell carcinoma identified on pathologic testing and confirmed
the absence of disease in the remaining 12 (71%) lymph nodes. The statistical analysis of these
results revealed a sensitivity of 80%; specificity, 100%; positive predictive value, 100%; and
negative predictive value, 92.3%. The diagnostic accuracy of ultrasonography-guided FNA at
detecting residual persistent cancer was 88%.
CONCLUSIONS AND RELEVANCE This pilot study suggests that ultrasonography-guided FNA
may be a feasible ancillary diagnostic imaging tool to imaging to assess patients with
radiographic persistent disease prior to consideration of salvage neck dissection.
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H ead and neck squamous cell carcinoma (HNSCC) af-fects approximately500000patientsworldwideeachyear, frequently metastasizing to cervical lymph
nodes. At initial presentation alone,more than half of the pa-
tients affectedwithHNSCC exhibit clinical evidence of cervi-
cal node metastasis.1-3
Primary chemoradiotherapy (CRT) is a well-established
treatment for locally advanced HNSCC.4-6 However, not ev-
ery patient has complete response to this treatment modal-
ity, necessitating eventual salvage neck dissection.
Although the rate of persistent disease after primarynon-
surgical therapyhasbeen reported7 tobeashighas40%, iden-
tifying patients with residual disease has been fraught with
challenge. Persistent clinical and radiographic adenopathy is
frequently seen after nonsurgical therapy but does not nec-
essary implypathologicdisease.Furthermore, studies8-12have
shown that approximately 80%ofpatientswhoundergoneck
dissection after receiving CRT have no viable tumor detected
on permanent pathologic examination. The dilemma, there-
fore, ishowtodetect truehistopathologicdiseasewithoutper-
formingadiagnosticneckdissection.Combinedpositronemis-
sion tomographic (PET)andcomputed tomographic (CT) scans
have been proposed to help further select patients with re-
sidual disease.However, althoughobtaining aPET/CT scan 12
weeks after therapy is themost commonpractice, there is still
debate over the timing of the scan, its sensitivity and speci-
ficity, and the future management of the treatment for these
patients.13,14
Preliminarydatasuggest thatultrasonography-guidedfine-
needle aspiration (FNA) is a highly accurate, safe, and inex-
pensive method of assessing lymph node metastasis in un-
treatedHNSCC.However, limiteddataareavailable toevaluate
the efficacy of this technique in the setting of prior CRT.15
Our aim was to conduct a pilot study to evaluate the fea-
sibilityanddiagnosticaccuracyofultrasonography-guidedFNA
at detecting persistent malignant cells in the lymph nodes of
patients with HNSCC after definitive treatment with CRT.We
hypothesized that ultrasonography-guided FNA would have
similar sensitivity, specificity, andaccuracy inpatientswho re-
ceived CRT and therefore can more accurately predict which
patients will benefit from salvage neck dissection.
Methods
Patients
All patients with locally advanced (categories N1, N2, or N3)
HNSCCtreatedwithprimarynonsurgical therapybetweenFeb-
ruary 28, 2011, and March 18, 2013, were eligible for this in-
vestigation. With the use of American Joint Committee on
Cancer16 oncologic staging, any T, N1 to N3, and M0 catego-
ries were included.
The cases of patients were presented to the University of
NorthCarolinaHospitalsMultidisciplinaryTumorBoard;at that
time, imaging was reviewed by a board-certified neuroradi-
ologist, results of pathologic examinationwere reviewedby a
board-certified pathologist, and plan of care was determined
byateamofmedicaloncologists, radiotherapyoncologists, and
head and neck surgeons. Patientswith persistent cervical ad-
enopathy noted on CT imaging after definitive CRT forwhom
themultidisciplinary tumorboard recommendedsalvageneck
dissectionwere included in this study. A secure databasewas
maintained and results were recorded by a deidentified nu-
meric system.
All patients providedwritten informed consent to partici-
pate.Financial compensationwasnotprovided.Thestudywas
approved by the University of North Carolina Biomedical In-
stitutional Review Board and met the tenets of the Declara-
tion of Helsinki.17
Treatment Plan
All patients with node-positive HNSCC received standard-of-
care, definitive primary nonsurgical therapy: chemotherapy,
radiotherapy, or CRT with curative intent. At the time of this
study, our institutional standard of care was to perform a
6-week posttreatment CT scan following CRT and then insti-
tute therapy (eg, neck dissection) based on the results of the
scan.Everypatient receivedposttreatment imaging in the form
of a contrastedCT scanperformed4 to6weeks after complet-
ing primary CRT. The CT scanwas independently interpreted
by a neuroradiologist.
Computed tomographic criteria for the diagnosis of
residual disease included (1) short-axis (>1.0 cm) or long-axis
(>1.5 cm)diameter size, (2) internal heterogeneity of thenodal
parenchyma, or (3) significant enhancement. Patients with
residual disease noted on imaging were selected to undergo
immediate salvage neck dissection in accordance with the
National Comprehensive Cancer Network Guidelines.18
Ultrasonography-Guided FNA
Ultrasonography-guided FNA was performed by one of us
(T.G.H.) within 2 to 4 weeks of the 6-week posttreatment CT
scan and within 2 weeks of the planned neck dissection and
was targeted at the lymph nodes seen on the posttreatment
CT scan. The target lymph node appearance on ultrasono-
graphic imaging was also recorded and included rounded
shape, size (>1.0 cm), hyperechogenicity, cystic appearance,
hyperechoic punctuations, loss of hilum, and peripheral
vascularization.19 The location of each nodewas carefully re-
corded to correlatewith the location indicatedon theCT scan.
Ultrasonography-guidedFNAwas performedusing a 10-mHz
linear arrayprobewith2passesof a23- to25-gaugeneedle into
each lymphnode. Each node deemed suspicious on the post-
treatment CT was biopsied.
Touchprepandformalin-fixedslideswerepreparedbyone
of us (T.G.H.), deidentified by a randomnumeric system, and
then sent by courier to a blinded cytopathologist (M.D.) who
independently reviewed thesedeidentified samples.These re-
sultsof thecytologicexaminationweredeterminedbefore sur-
gery,were kept confidential, andwere not included in the pa-
tient’s medical record.
Salvage Neck Dissection
Based on existing standard institutional head and neck tu-
mor board protocol, a planned neck dissection was sched-
uled if anything less than a radiographic complete response
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was noted on the post-CRT CT scan. The decision to perform
a neck dissection was made before consideration of enroll-
ment in this study. The type of neck dissection (eg, modified
radical, selective, superselective, or nodal pluck) to be per-
formed was selected at the discretion of the surgeon.
The borders of each nodal neck level in the neck dissec-
tionspecimenwerecarefullydelineatedand taggedby thesur-
geon according to the American Academy of Otolaryngology,
Head, and Neck Surgery classification system.20 The lymph
nodes assessed as “concerning” on the CT scan preopera-
tivelywere sent separately from the remaining specimen.The
specimenwas fixed in formalin in theoperating roomandsent
to the pathology laboratory for histologic evaluation.
Cytologic and Pathologic Testing
The neck dissection specimens underwent routine patho-
logic processing. Hematoxylin-eosin staining of the neck dis-
section specimenswasperformed, andhistopathologic speci-
mens were interpreted by the pathologists whowere blinded
to the results of the FNA as part of stand-of-care treatment.
Evaluation and Assessment of Ultrasonography-Guided FNA
Todetermine the accuracyof ultrasonography-guidedFNA in
identifying pathologic residual disease in lymph nodes of
HNSCC patients 6 to 8 weeks after treatment with definitive
CRT,ultrasonography-guidedFNAcytologic resultswere com-
paredwithmatched neck dissection specimens, and the sen-
sitivity and specificity of the cytologic results were com-
pared with the standard of histopathology.
Statistical Analysis
Cytologic results were coded as no lymphoid cells identified,
no malignant cells identified, and squamous cell carcinoma
(SCC).Histopathologic findings fromsubsequentneckdissec-
tions were classified as no tumor present, residual SCC pres-
ent,andnecrosisorchronic inflammationconsistentwithtreat-
ment effect present. Cytologic resultswere comparedwith the
standard of histopathology. Sensitivity, specificity, and nega-
tiveandpositivepredictivevalueswerecalculated.Dataanaly-
sis was conducted from April 28 to December 24, 2013. Sta-
tistical analysis was performed using SOFA, version 1.4.6
(Paton-Simpson & Associates Ltd).
Results
Thestudypopulationwasacohortof 14adults (aged≥18years)
with SCC of the nasopharynx, oropharynx, larynx, oral cav-
ity, orhypopharynx treatedwithCRTwith curative intent. The
stage at presentation, results of nodal aspirates, and histo-
logic examination results are summarized in the Table.
Fourteen consecutive patients with HNSCC with incom-
plete radiographic clinical responseon their post-CRTCTscan
were enrolled in the study in aprospectivemanner. The study
populationconsistedof 11men (79%)and3women (21%),with
amean (SD) age of 57.8 (11.2) years (range, 41-80 years). Loca-
tion of the primary tumor was the oropharynx in 12 patients
(86%)andsupraglottic larynx in2patients (14%).Clinicalnodal
stage at presentationwas categoryN0 in 1patient,N2a in2pa-
tients, N2b in 6 patients, N2c in 4 patients, and N3 in 1 pa-
tient. Thepatientwho initially presentedwith categoryT3N0
prior to CRT had a suspicious node at the completion of CRT
identified on the6-weekposttreatmentCT scan,which in ret-
rospect was also present on pretreatment films (1.2 cm, level
2 of the ipsilateral neck) but was not indicated as positive at
that time. After treatment, this lymphnode showed concern-
ing necrosis warranting removal.
Among the 14patientswith incomplete radiographic clini-
cal response, 17 lymphnodeaspirationswereperformed.Each
lymph node suspicious for residual disease based on CT cri-










M/71 T2N2bM0 SCC L BOT after CRT Negative Negative Direct
M/57 T4N3M0 OP SCC after CRT Negative Negative Direct
F/53 T3N2cM0 SGL SCC after CRT Negative Negative Direct
M/57 T3N2cM0 SCC L BOT after CRT Negative Negative Direct
F/60 Stage IV OP SCC after CRT Positive Positive Direct
M/50 T1N2bM0 SCC L tonsil after CRT Negative Negative Direct
M/41 T2N2bM0 SCC OP after CRT Positive Positive Direct
M/50 T2N2bM0 SCC OP after CRT Negative Negative Direct
M/80 TxN3M0 SCC after CRT Positive Positive Direct
F/53 T2N2bM0 SCC OP after CRT Positivea Negative FNA missed SCCa
M/44 T2N2cM0 SCC R tonsil after CRT Negative Negative Direct
Negative Negative Direct
Negative Negative Direct
M/54 T2N2bM0 SCC L BOT after CRT Negative Negative Direct
M/65 T3N0M0 SCC SGL after CRT Positive Positive Direct
M/74 T4N2cM0 SCC L BOT after CRT Negative Negative Direct
Negative Negative Direct
Abbreviations: BOT, base of tongue;
CRT, chemoradiotherapy;
FNA, fine-needle aspiration; L, left;
OP, oropharynx; R, right;
SCC, squamous cell carcinoma;
SGL, supraglottic.
a Focus of remnant SCC on
permanent pathologic testing in the
lymph nodemeasured 1 mm.
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teriawas biopsied twice, and all (100%)of the sampled lymph
nodesweredeemed satisfactory for cytologic diagnosis. All of
theposttreatment lymphnodes sampledonultrasonography-
guided FNAwere rounded, showed a heterogeneous internal
appearance, andhadnodistinct hilum. In retrospect, thema-
lignant lymphnodeswerenot distinct in appearance from the
benign treated lymphnodes.Onhistologic analysis of theneck
dissection samples, nomalignant cellswere found in 12 (71%)
of the 17 nodes (Figure). Squamous cell carcinomawas, how-
ever, identified on permanent pathologic examination in
5 lymphnodespecimens.Ultrasonography-guidedFNAdidnot
detect the presence of any malignant cells in the 12 aspirates
that hadnegative results onpathologic examination.Ultraso-
nography-guided FNA correctly indicated SCC in the aspi-
rates of 4 (80%) of these 5 SCC-positive nodes butwas unable
to detect a minute focus of viable squamous cells in 1 of the
nodes.Therewerenonondiagnostic samples in this study.The
statistical analysis of these results revealed sensitivity, 80%;
specificity, 100%; positive predictive value, 100%; and nega-
tive predictive value, 92.3%. The diagnostic accuracy of ul-
trasonography-guidedFNAatdetecting residualpersistentma-
lignant cells was 88%.
Discussion
At the inception of primary CRT for HNSCC, all patients re-
ceived planned posttreatment neck dissections regardless of
theirclinical responsetotherapy.Theseneckdissectionsserved
both a diagnostic and therapeutic role. Much has changed in
the treatment algorithm since the early 2000s. Combination
CRT, better imaging protocols, and a shift in the epidemiol-
ogy of HNSCC to include human papillomavirus have af-
fected current treatment protocols dramatically.21
With improved diagnosticmeasures, such as PET and CT,
and given the low incidence of residual neck disease identi-
fiedonplannedposttreatmentneckdissection, treatmentpara-
digms have shifted in the attempts to avoid oncologically un-
necessary neck dissections, which carry an additional
morbidity without benefit. The management of locally ad-
vanced HNSCC has evolved from routine neck dissections to
a more methodical assessment of tumor response, with sal-
vage surgery reserved for patients with clinical or radio-
graphic evidence of residual disease.
Despite thevast improvement indiagnosticcapabilitiesand
the epidemiologic shift in the disease, the question remains:
canwe identify at-risk patients earlier andmore accurately so
as to expedite their oncologic care and prevent the remaining
population from receiving unnecessary therapy?
At present, several diagnostic modalities are used to as-
sess lymph node response to primary nonsurgical treatment
and, therefore, the need for a posttreatment neck dissection.
Computed tomography is a commonly used diagnostic mo-
dality to evaluate postradiotherapy residual neck disease.
When assessedwith strict radiographic criteria (lymphnodes
>1.5 cm, focal lucency, and extracapsular extension), CT
has a high sensitivity but a low specificity (97% and 37%,
respectively).22 As a result, patientswith less than a complete
response noted onCT require a neck dissection,which serves
both diagnostic and potentially therapeutic purposes. How-
ever, there is strong clinical evidence that most patients who
undergo salvage neck dissections ultimately have a normal
neck dissection specimen and, therefore, a pathologic com-
plete response.8-12Thus,manyof thesepatients incur themor-
bidity but not the benefit of a salvage neck dissection.
PET/CT scans have garnered popularity for the assess-
ment of tumor response tononsurgical treatment and, subse-
quently, to guide recommendations for adjuvant neckdissec-
tions. The increasedmetabolic activity of tumor cells leads to
an increased uptake of fludeoxyglucose F 18 compared with
normal tissue.However, inflammatory cells present in freshly
radiated tissue also have an avid uptake of fludeoxyglucose
F 18, leading to false positivity on PET/CT scans for up to
3 months after radiotherapy.23 Delaying a PET/CT scan until
after the inflammation subsides potentially places the pa-
tient outside the optimal operative window, as dense postra-
diotherapyfibrosisbegins toaffect thetissues, leadingtoamore
technically difficult salvage surgery. In addition, the false-
positive rate on a 12-weekposttreatment PET/CT scan is lower
than that of a 6-week posttreatment PET/CT.
Salvage neck dissection in patients whose nonsurgical
treatment has failed is associated with high morbidity and a
Figure. Comparison of Permanent Histopathologic and Ultrasonography-Guided Fine-Needle Aspiration (FNA)
Cytologic Testing
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CT indicates computed tomography;
SCC, squamous cell carcinoma.
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lower probability of cure. Ameta-analysis by Goodwin24 that
used studies published between 1980 and 1998 showed an
overall 5-year survival rateofonly39%inpatients treatedwith
salvage neck dissection after definitive radiotherapy as their
primary treatment modality. Agra et al25 confirmed the poor
prognosis of salvage neck dissection in a study of 96 patients
whose cancer recurred after radiotherapy, demonstrating a
5-year survival rate of only 25.3%.With this “wait andwatch”
approach, the tumor has often already become affixed to vi-
tal structures in the neck by the time the regional failure is di-
agnosed, making most of these recurrent tumors unresect-
able after definitiveCRT. Similarly, at our institution,wehave
observeda2-year survival rateof27%after salvage surgery fol-
lowingCRT failure. The ideal test to select patientswhowould
benefit from posttreatment neck dissection would be highly
sensitive to conclusively detect occult disease, would be spe-
cific enough to avoid unnecessary neck dissection in patients
withoutdisease, andwouldyielddependable results ina time-
sensitive manner.
In prior studies,19,26-29 ultrasonography-guided FNA has
beenwelldocumentedasanaccurateandcost-effectivemethod
for assessing patients for lymph node metastasis in HNSCC.
Knappeetal19assessed56patientswithultrasonography-guided
FNAprior to neck dissection and found the procedure to have
sensitivity, specificity, and accuracy values of 89.2%, 98.1%,
and 94.5%, respectively. Furthermore, van den Brekel et al28
determined thatultrasonography-guided–aspirationcytologic
examination was significantly more accurate than clinical
palpation,CT,ormagnetic resonance imagingat staging lymph
node disease.
However, despite the high accuracy of ultrasonography-
guidedFNAindetectingnodaldisease, itsability to identifyper-
sistent disease in the neck after CRThas not been conclusively
studied.30,31 Our pilot study aimed to assess the usefulness of
ultrasonography-guided FNA in the neck after CRT. Ultraso-
nography-guided FNA of cervical lymph nodes was per-
formed in 14 patientswithHNSCCwith persistent adenopathy
demonstratedonCTscanningof theneckwith contrast imme-
diately before their neck dissection. The accuracy of ultraso-
nography-guided FNA was assessed by correlating the cyto-
logicexamination resultsdeterminedusingneedlebiopsywith
the permanent pathologic findings from the neck dissection
specimens. Ultrasonography-guidedFNAyielded a sensitivity
of 80%, specificity of 100%,positivepredictivevalueof 100%,
and negative predictive value of 92.3%, with a diagnostic ac-
curacy of detecting residual persistent carcinoma of 88%.
In our study, the one false-negative ultrasonography-
guided FNA specimenwas seen in a patient with only 1mmof
viable cancer within a background of necrosis on final patho-
logic examination 8 weeks after CRT. The FNA results did not
show the disease, which points out that one of the limitations
of this technique is the potential sampling error of microme-
tastasis. In addition, ultrasonography-guided FNA is operator
dependent and does not assess the primary site, chest, medi-
astinum, or retropharyngeal zones. Although ultrasonogra-
phy isasuperior imagingtool forassessingthyroidandneckdis-
ease, we are not suggesting that it should or can replace CT or
PET/CT scans. Furthermore, although ultrasonography pro-
vides excellent nodal detail and allows for detection of intra-
nodal micrometastasis in the untreated neck, the same posi-
tive predictive value is not seen immediately after treatment.
Theclassic criteria of roundshape,heterogeneous core, lackof
ahilum,andcalcificationswereseen in thepersistentadenopa-
thy in this study regardless of thepresenceof viablemalignant
cells. Radiation-induced nodal necrosis likely clouds the effi-
cacy of ultrasonography as a purely diagnostic tool in this set-
ting, and its guidanceof theFNA iswhere its value lies. Rather,
wepropose thatultrasonography-guidedFNAbeconsidered in
the diagnostic algorithm as a means of improving selection of
patients for salvagenecksurgerywhendisease is suggested fol-
lowing a 6-week CT or 12-week PET/CT scan.
Ultrasonography costs much less than neck dissection or
PET/CT, and the addition of FNA adds a vital pathologic as-
sessmentof the tissue.With thepotential diagnostic yield and
low-cost impact,ourpilot studysuggests thatultrasonography-
guided FNAmay add value to themanagement of care for pa-
tients with persistent neck disease following CRT for HNSCC.
Based on our results, we believe that ultrasonography-
guidedFNAmayhave a role in thediagnostic algorithm inpa-
tientswith locallyadvancedHNSCCwithpersistentdisease fol-
lowing CRT observed on a posttreatment CT or PET/CT scan
before or after a 12-week posttreatment PET/CT.32 Conduct-
ing ultrasonography-guided FNA in these patientsmay allow
surgeons to accurately detect the presence or absence of vi-
able tumor cells in a time- and cost-efficientmanner, thereby
avoidingunnecessaryneckdissectionsordelays indisease rec-
ognition.Wealso believe that ultrasonography-guidedFNA is
particularly useful for patients with a clinical partial re-
sponse, sincewaitingona 12-weekposttreatmentPET/CTscan
may not be feasible or may delay necessary salvage surgery.
Finally, additional limitationsofour study include the lack
of a PET/CT arm and the low power. Our low numbers do not
permit an accurate assessment of efficacy. However, we be-
lieve that this pilot study suggests the potential low-risk and
low-cost benefit of addingultrasonography-guidedFNAto the
diagnostic algorithm in this patient population and therefore
warrantsmore formal investigation ina largemulticenter trial.
Conclusions
Ultrasonography-guided FNA may provide a cost-effective
methodforassessingpatientswithpossiblepersistentneckdis-
ease following CRT during the optimal surgical window. Fur-
ther studiesarewarranted tobetterquantify theefficacyof this
diagnostic modality.
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